Reusable respiratory endoscopy market seen reaching $2.16B by 2030

The reusable respiratory endoscopy market is projected to grow from $1.41 billion in 2025 to $2.16 billion by 2030, driven by chronic respiratory disease cases, AI-assisted diagnostics and demand for reusable devices. North America led the market in 2025, while Asia-Pacific is expected to grow fastest.

Why it matters: - Reusable respiratory endoscopy is becoming more important as hospitals and clinics look for lower-cost, repeat-use tools for diagnosing and treating airway and lung conditions. - The market's growth points to rising demand for minimally invasive respiratory procedures and better imaging in pulmonary care.

What happened: - The reusable respiratory endoscopy market is projected to rise from $1.41 billion in 2025 to $1.53 billion in 2026, an 8.8% compound annual growth rate. - The market is forecast to reach $2.16 billion by 2030, at a 9.0% CAGR. - The Business Research Company released the outlook on Sept. 14, 2026. - The company published a free sample of the market report. - The company also published the full market report.

The details: - Reusable respiratory endoscopy uses durable, sterilizable instruments designed for repeated clinical use. - The tools are used to visually examine, diagnose, monitor and guide treatment in the respiratory tract, including airways and lung structures. - The market's historical growth has been driven by the rising prevalence of chronic respiratory diseases, broader use of flexible bronchoscopy, better endoscopic imaging, more pulmonary care facilities in hospitals and stronger physician training in minimally invasive techniques. - Future growth is expected to come from AI support for respiratory diagnostics, more outpatient and ambulatory procedures, broader use of personalized pulmonary treatments, higher demand for reusable devices to cut costs and continued advances in high-resolution imaging and visualization. - Notable trends include greater use of sterilizable bronchoscopes, stronger demand for high-definition imaging, preference for minimally invasive approaches in critical care, expansion of outpatient endoscopy services and stricter infection-control protocols that favor advanced sterilization methods. - Chronic respiratory diseases such as COPD, asthma, pulmonary fibrosis and occupational lung diseases remain a major driver because they require repeated diagnostic and therapeutic procedures. - The American Medical Association projected in December 2023 that global COPD cases will rise by 112 million to 592 million by 2050, or 9.5% of the eligible population. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region in the coming years. - The report also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa.

Between the lines: - Reusable devices fit a broader healthcare push to control costs while maintaining procedural quality. - AI and improved visualization suggest the category is moving from basic instrumentation toward more data-supported diagnosis. - The regional growth split implies mature demand in North America and faster capacity buildout across Asia-Pacific.

What's next: - Market growth will likely track respiratory disease prevalence, hospital adoption of reusable systems and outpatient procedure volumes. - More product development should focus on image quality, sterilization efficiency and AI-enabled diagnostic support. - The report says its 2026 editions include market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, hotspot infographics and updated trend analysis. - The company provided contact details for expert consultation and social channels, including LinkedIn, Facebook and X.

The bottom line: - Reusable respiratory endoscopy is positioned for steady expansion as healthcare systems face more chronic lung disease, more outpatient care and pressure to balance quality with cost.